March 23, 2020
In the wake of the escalating global COVID-19 pandemic, the need for rapid development of effective vaccines and other therapeutic agents has never been greater. Each day, more and more companies and research institutions are taking up the charge to identify new therapeutic interventions to fight the spread of the disease around the world.
At Metabolon, we have activated the necessary business continuity processes to allow us to continue to serve our clients and help support advancing research – including research related to COVID-19.
As a BSL-2 certified lab, Metabolon is equipped to safely receive and process any human or non-human biofluid samples containing COVID-19. As the world leader in global metabolomics sample processing and biological interpretation, Metabolon is uniquely positioned to provide rapid answers around biologic pathways of disease progression, insights into efficacy of adjuvant systems, and metabolic signatures of therapy response.
In the face of the urgent need to discover new biological insights about COVID-19, we are offering all clients expedited processing of COVID-19 related projects, with a commitment to deliver COVID-19 related projects in half the time of our standard turnaround times. In addition, we have assembled a dedicated team of study directors to address client questions, lead study design and draft final biological interpretation reports
We are eager to join you in the fight to stop this global health crisis. Please contact your Metabolon Sales Representative or email us at firstname.lastname@example.org to discuss your specific program needs.
The Metabolon Team